Amer M H, el-Akkad S
Department of Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Gastroenterology. 1994 Apr;106(4):846-58. doi: 10.1016/0016-5085(94)90742-0.
BACKGROUND/AIMS: Gastrointestinal lymphoma is a rare disease. A study was conducted to assess its prevalence and clinical features in adult patients with lymphoma.
Retrospective analysis of 1352 patients with adult non-Hodgkin's lymphoma showed 300 (22%) cases with gastrointestinal involvement at initial presentation.
Of the 185 patients with primary gastrointestinal lymphoma, 94 (51%) had gastric primary lymphoma and the rest (49%) had a lymphoma of intestinal origin. Patients with intestinal lymphoma were considerably younger (median age, 35.0 years), frequently had multifocal disease (14%), and had a 10-year survival rate of 48%. Cases with gastric primary lymphoma had a median age of 54.5 years (P < 0.001) and rarely had multifocal disease (1%; P < 0.001) but had an equal 10-year survival rate of 53% (P = 0.431). For both groups, the combined surgical resection followed by chemotherapy led to better 10-year survival (45%) compared with either modality used alone (0% and 35%, respectively; P < 0.05). Better survival was also noted in ambulatory patients, younger patients, those with localized disease, and those without intestinal perforation. Another 115 patients had gastrointestinal involvement secondary to disseminated disease with frequent high-grade histology (29%) and a poor 10-year survival rate of 22%.
Gastrointestinal involvement is relatively common in patients with adult lymphoma. Multimodality treatment appeared superior to therapy with either surgery or chemotherapy used alone.
背景/目的:胃肠道淋巴瘤是一种罕见疾病。开展了一项研究以评估其在成年淋巴瘤患者中的患病率及临床特征。
对1352例成年非霍奇金淋巴瘤患者进行回顾性分析,结果显示300例(22%)患者初诊时存在胃肠道受累情况。
在185例原发性胃肠道淋巴瘤患者中,94例(51%)为原发性胃淋巴瘤,其余(49%)为肠道原发性淋巴瘤。肠道淋巴瘤患者明显更年轻(中位年龄35.0岁),多灶性病变常见(14%),10年生存率为48%。原发性胃淋巴瘤患者的中位年龄为54.5岁(P<0.001),很少有多灶性病变(1%;P<0.001),但10年生存率相同,为53%(P=0.431)。对于两组患者,与单独使用手术或化疗相比,联合手术切除后化疗可带来更好的10年生存率(45%)(单独使用手术和化疗的10年生存率分别为0%和35%;P<0.05)。门诊患者、年轻患者、局限性病变患者及无肠穿孔患者的生存率也更高。另有115例患者因播散性疾病继发胃肠道受累,组织学分级多为高级别(29%),10年生存率低,为22%。
胃肠道受累在成年淋巴瘤患者中相对常见。多模式治疗似乎优于单独使用手术或化疗。